Featured Research

from universities, journals, and other organizations

Scientists shut down pump action to break breast cancer cells' drug resistance

Date:
October 5, 2011
Source:
Ohio State University
Summary:
Breast cancer cells that mutate to resist drug treatment survive by establishing tiny pumps on their surface that reject the drugs as they penetrate the cell membrane -- making the cancer insensitive to chemotherapy drugs even after repeated use. Researchers have found a new way to break that resistance and shut off the pumps by genetically altering those breast cancer cells to forcibly activate a heat-shock protein called Hsp27.

Breast cancer cells that mutate to resist drug treatment survive by establishing tiny pumps on their surface that reject the drugs as they penetrate the cell membrane -- making the cancer insensitive to chemotherapy drugs even after repeated use.

Researchers have found a new way to break that resistance and shut off the pumps by genetically altering those breast cancer cells to forcibly activate a heat-shock protein called Hsp27. This protein regulates several others, including the protein that sets up the pumps that turn away the chemotherapeutics.

In experiments, the common chemotherapy drug Doxorubicin killed about 50 percent more drug-resistant breast cancer cells in which Hsp27 had been activated than it did in normal drug-resistant cells.

Though these results have been shown only in cell cultures in a lab, they suggest that there someday could be a clinical way to use this approach to reverse the drug resistance that can develop in breast cancer cells. The study was conducted in MCF-7/adr breast cancer cells, which resist the effects of Doxorubicin.

"These cells are actually resistant to multiple drugs, so the resistance will be there even if clinicians move on to other chemotherapeutics. It's a serious issue," said Govindasamy Ilangovan, associate professor of internal medicine at Ohio State University and senior author of the research. "The plausible way to circumvent this effect is to suppress the resistance by shutting down the drug extrusion pump using molecular approaches. That is what we're trying to address."

The study appears in the Sept. 23 issue of the Journal of Biological Chemistry.

The researchers analyzed proteins in regular breast cancer cells from the MCF-7 cell line as well as multidrug resistant cells from the same line. The normal breast cancer cells are known to be sensitive to chemotherapy drugs.

The tests indicated that the normal cells contained HSF-1, the transcription factor that activates the heat shock protein Hsp27. However, in the drug-resistant cells, HSF-1 was extremely low and Hsp27 was present in only trace amounts.

Previous research has established that Hsp27 controls two other proteins, including the culprit protein that makes the cells drug resistant by establishing pumps to extrude chemotherapeutics out of cells. This pumping protein's level was clearly high in the drug-resistant cells, and nonexistent in the normal breast cancer cells.

"The existence of this pump-action protein, called P-gp, is bad because it is removing the drugs from the cells. The cells do not even feel the presence of the drug in the system. We need to lower the amount of P-gp so that the drug stays in the cells to cause the intended damage. So we decided to model how to achieve this by forcibly bringing back the Hsp27," said Ilangovan, also an investigator in Ohio State's Davis Heart and Lung Research Institute.

In these experiments on cells, the researchers performed gene transfer using a viral vector to deliver the Hsp27 gene into the drug-resistant cells. As expected, after the addition of this gene the Hsp27 protein was abundantly induced and the drug-resistant protein p-gp went down in the cells.

"Then we tested the cells under this condition to determine whether we could sensitize these resistant cells to the drug," Ilangovan said.

After treatment with varying levels of Doxorubicin, about 50 percent more resistant cells in which Hsp27 had been forcefully activated died compared to normal drug-resistant cells. In addition, fluorescent staining of the cells showed that the expression of Hsp27 in these cells also caused them to absorb much more of the chemotherapy drug -- a sign the drug was not being pumped away.

Additional experiments showed that these genetically altered cells died in the way they typically would in response to chemotherapy -- by undergoing a programmed cell death process called apoptosis.

"We proved Doxorubicin does kill these cells in the way it is supposed to," Ilangovan said.

The findings represent a twist of sorts in molecular biology because heat-shock proteins typically are activated by stress. But in this case, the drug-resistant cells become reprogrammed over time -- presumably, in response to the stress of being treated with drugs intended to kill them -- and instead of being full of heat-shock protein activity, those stress-induced proteins are silenced.

"Because these proteins are involved, it looks at present like there could be a strong link between chronic stress and this drug-resistant mechanism evolving in the cells, but we need to carry out additional new studies to make any solid conclusion on chronic stress and drug resistance in cancer," Ilangovan said.

Translation of this technique in humans is years away, but would likely involve the delivery of the Hsp27 gene into drug-resistant cancer cells to induce activation of the Hsp27 protein, he said. The next step in this work involves refining the gene transfer process and demonstrating it in animal models.

The National Institutes of Health supported this research.

Co-authors include Ragu Kanagasabai and Karthikeyan Krishnamurthy of the Division of Cardiovascular Medicine and Davis Heart and Lung Research Institute, and Lawrence Druhan of the Department of Anesthesiology, all at Ohio State.


Story Source:

The above story is based on materials provided by Ohio State University. The original article was written by Emily Caldwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. R. Kanagasabai, K. Krishnamurthy, L. J. Druhan, G. Ilangovan. Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux and MDR1 Gene Expression in Adriamycin-resistant Human Breast Cancer Cells. Journal of Biological Chemistry, 2011; 286 (38): 33289 DOI: 10.1074/jbc.M111.249102

Cite This Page:

Ohio State University. "Scientists shut down pump action to break breast cancer cells' drug resistance." ScienceDaily. ScienceDaily, 5 October 2011. <www.sciencedaily.com/releases/2011/09/110928110010.htm>.
Ohio State University. (2011, October 5). Scientists shut down pump action to break breast cancer cells' drug resistance. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/09/110928110010.htm
Ohio State University. "Scientists shut down pump action to break breast cancer cells' drug resistance." ScienceDaily. www.sciencedaily.com/releases/2011/09/110928110010.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins